Homocysteine and arterial disease - Experimental mechanisms

Author： Cook J.W.   Taylor L.M.   Orloff S.L.   Landry G.J.   Moneta G.L.   Porter J.M.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.38, Iss.5, 2002-05, pp. : 293-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocysteine in Neurological Disease: A Marker or a Cause?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 361-369

Bentham Science Publishers

Access to resources Recommend Favorite

Homocysteine and Non-Cardiac Vascular Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 22, 2017-09 ,pp. : 3224-3232

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Medial Arterial Calcification in Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 37, 2014-11 ,pp. : 5870-5883

Bentham Science Publishers

Access to resources Recommend Favorite

Cilostazol and peripheral arterial disease

By Pearce Lyndsay   Ghosh Jonathan   Counsell Andrew   Serracino-Inglott Ferdinand  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Hypertension in Peripheral Arterial Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3615-3620

Bentham Science Publishers

Access to resources Recommend Favorite